For the quarter ended March 2025, Globus Medical (GMED) reported revenue of $598.12 million, down 1.4% over the same period last year. EPS came in at $0.68, compared to $0.72 in the year-ago quarter.
The reported revenue represents a surprise of -4.81% over the Zacks Consensus Estimate of $628.32 million. With the consensus EPS estimate being $0.74, the EPS surprise was -8.11%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Globus Medical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Geographic Revenues- International: $114.26 million versus the three-analyst average estimate of $127.52 million. The reported number represents a year-over-year change of -7.7%.
- Geographic Revenues- United States: $483.86 million versus the three-analyst average estimate of $510.72 million. The reported number represents a year-over-year change of +0.2%.
- Net Sales by Product Category- Enabling Technologies: $22.19 million versus $38.79 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -30.6% change.
- Net Sales by Product Category- Musculoskeletal Solutions: $575.93 million versus $598.85 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +0.2% change.
View all Key Company Metrics for Globus Medical here>>>
Shares of Globus Medical have returned -3.7% over the past month versus the Zacks S&P 500 composite's +11.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Globus Medical, Inc. (GMED): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
